These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34789583)

  • 1. Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.
    Kim SY; Cho YS; Kim HS; Lee JK; Kim HM; Park HJ; Kim H; Kim J; Kang DR
    Gut Liver; 2022 Jul; 16(4):555-566. PubMed ID: 34789583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
    Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period.
    Hansen AT; Erichsen R; Horváth-Puhó E; Sørensen HT
    J Thromb Haemost; 2017 Apr; 15(4):702-708. PubMed ID: 28135041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study.
    Heo CM; Kim TJ; Kim ER; Hong SN; Chang DK; Yang M; Kim S; Kim YH
    Sci Rep; 2021 Jan; 11(1):2025. PubMed ID: 33479464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Weng MT; Park SH; Matsuoka K; Tung CC; Lee JY; Chang CH; Yang SK; Watanabe M; Wong JM; Wei SC
    Inflamm Bowel Dis; 2018 Jul; 24(8):1791-1800. PubMed ID: 29726897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry.
    Aardoom MA; Klomberg RCW; Kemos P; Ruemmele FM; ; van Ommen CHH; de Ridder L; Croft NM;
    J Crohns Colitis; 2022 Jun; 16(5):695-707. PubMed ID: 34599822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study.
    Kuenzig ME; Bitton A; Carroll MW; Kaplan GG; Otley AR; Singh H; Nguyen GC; Griffiths AM; Stukel TA; Targownik LE; Jones JL; Murthy SK; McCurdy JD; Bernstein CN; Lix LM; Peña-Sánchez JN; Mack DR; Jacobson K; El-Matary W; Dummer TJB; Fung SG; Spruin S; Nugent Z; Tanyingoh D; Cui Y; Filliter C; Coward S; Siddiq S; Benchimol EI
    J Crohns Colitis; 2021 Dec; 15(12):2031-2040. PubMed ID: 34175936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort.
    Rifkin AS; Shi Z; Wei J; Zheng SL; Helfand BT; Cordova JS; Biank VF; Tafur AJ; Khan O; Xu J
    World J Gastroenterol; 2023 Oct; 29(39):5494-5502. PubMed ID: 37900992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study.
    Bernstein CN; Nugent Z; Singh H
    Am J Gastroenterol; 2021 Jul; 116(7):1476-1484. PubMed ID: 33767104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Scoville E; Konijeti GG; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1905-10. PubMed ID: 24632349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Faye AS; Hung KW; Cheng K; Blackett JW; Mckenney AS; Pont AR; Li J; Lawlor G; Lebwohl B; Freedberg DE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1394-1400. PubMed ID: 31689354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in inflammatory bowel disease.
    Cheng K; Faye AS
    World J Gastroenterol; 2020 Mar; 26(12):1231-1241. PubMed ID: 32256013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.
    Sam JJ; Bernstein CN; Razik R; Thanabalan R; Nguyen GC
    Dig Dis Sci; 2013 Jan; 58(1):46-52. PubMed ID: 23053902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
    Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line.
    Hamant LG; Gonzalez-Llanos L; Patel AS; McMahon L; Knoll C; Swing T; Pasternak B
    J Pediatr Gastroenterol Nutr; 2023 May; 76(5):610-615. PubMed ID: 36821846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.
    Chu TPC; Grainge MJ; Card TR
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1099-1108. PubMed ID: 30294897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
    Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
    J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.